Novartis’ Rhapsido has won approval in Europe, while Coartem Baby has received WHO prequalification.

The FDA's approval of the new dosing option for Omlyclo addresses the diverse needs of patients with allergic and inflammatory conditions. "The approval of the additional 300 mg presentation of Omlyco ...

(RTTNews) - Celltrion Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO (omalizumab-igec)—the first and only biosimilar designated as ...

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose escalation process, according to a new study presented at the American ...

Please provide your email address to receive an email when new articles are posted on . Data came from the FDA Adverse Event Reporting System from 2004 to 2024. Omalizumab had significant associations ...

Add Yahoo as a preferred source to see more of our stories on Google. Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, particularly ...

Xolair (omalizumab) has no known interactions with alcohol, other medications, or supplements. But Xolair might not be safe for people with certain conditions or other health factors. Xolair is a ...

Omalizumab is effective and safe for severe allergic asthma and chronic urticaria, with no significant adverse reactions reported over two decades. Remibrutinib, a Bruton tyrosine kinase inhibitor, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Findings showed equivalent efficacy in change from baseline in weekly itch severity score between omalizumab-igec 300mg and Xolair 300mg. The Food and Drug Administration (FDA) has approved Omlyclo ® ...

Blue Cross Blue Shield of Oklahoma (BCBS), including BCBS plans in states of Illinois, New Mexico, Texas and Montana, is requiring patients insured with them who have severe asthma to inject ...